The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
Open accessAbstract
Cancer cells adapt their metabolic processes to support rapid proliferation, but less is known about how cancer cells alter metabolism to promote cell survival in a poorly vascularized tumour microenvironment. Here we identify a key role for serine and glycine metabolism in the survival of brain cancer cells within the ischaemic zones of gliomas. In human glioblastoma multiforme, mitochondrial serine hydroxymethyltransferase (SHMT2) and glycine decarboxylase (GLDC) are highly expressed in the pseudopalisading cells that surround necrotic foci. We find that SHMT2 activity limits that of pyruvate kinase (PKM2) and reduces oxygen consumption, eliciting a metabolic state that confers a profound survival advantage to cells in poorly vascularized tumour regions. GLDC inhibition impairs cells with high SHMT2 levels as the excess glycine not metabolized by GLDC can be converted to the toxic molecules aminoacetone and methylglyoxal. Thus, SHMT2 is required for cancer cells to adapt to the tumour environment, but also renders these cells sensitive to glycine cleavage system inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitochondrial serine hydroxymethyltransferase (SHMT2) is required for cancer cells to adapt to the tumor environment.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [60]
In the citing paper
“SHMT2 also plays a role in redox balance.”
From A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight (2021) · cites this paper as [127]
In the citing paper
“Additionally, expression of SHMT2 promotes survival in the ischemic tumor microenvironment in glioma.”
From A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight (2021) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Sundaram, S. K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T. R., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,719
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Self-citationExploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Lee, J., Kotliarova, S. E., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,345
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Cited by
Sorted by citations
Items 201–300 of 372
The role of SHMT2 in modulating lipid metabolism in hepatocytes via glycine-mediated mTOR activation
Choi, Y., Lee, G., Yun, S. H., Lee, W., Yu, J., Kim, S. K., & Lee, B. (2022) · Amino Acids · doi:10.1007/s00726-022-03141-9 · Cited by 23
Xie, S.-Y., Shi, D., Ouyang, Y. Q., Cheng, X.-Y., Chen, X., Jiang, T., Xia, W., Guo, L., & Lin, H. (2021) · Research Square · doi:10.21203/rs.3.rs-1016628/v1 · Cited by 22
MicroRNA‐628‐5p inhibits cell proliferation in glioma by targeting DDX59
Xie, P., Wang, Y., Liao, Y., Han, Q., Qiu, Z., Chen, Y., & Zuo, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28991 · Cited by 21
The role of dNTP metabolites in control of the embryonic cell cycle
Liu, B., & Großhans, J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1665948 · Cited by 21
Li, Q., Chen, H., Zhang, M., Wu, T., Liu, R., & Zhang, Z. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b04860 · Cited by 21
Xing, J., Qi, X., Liu, G., Li, X., Gao, X., Bou, G., Bai, D., Zhao, Y., Du, M., Dugarjaviin, M., et al. (2023) · Animals · doi:10.3390/ani13020208 · Cited by 20
Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer
Wang, H., Chong, T., Li, B.-Y., Chen, X.-S., & Zhen, W.-B. (2020) · Biological Research · doi:10.1186/s40659-020-00314-2 · Cited by 20
Rijal, G., Kim, B. S., Pati, F., Ha, D., Kim, S. W., & Cho, D. (2017) · Biofabrication · doi:10.1088/1758-5090/9/1/015013 · Cited by 20
Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells
Woo, C. C., Kaur, K., Chan, W. X., Teo, X. Q., & Lee., T. H. P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00196 · Cited by 19
Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance
Bailleul, J., & Vlashi, E. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0088 · Cited by 22
A five‑gene based risk score with high prognostic value in colorectal cancer
Pan, Y., Zhang, H., Zhang, M., Zhu, J., Yu, J., Wang, B., Qiu, J., & Zhang, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.7097 · Cited by 19
Farris, J. D., Calhoun, B., Alam†, M. S., Lee, S. W., & Haldar, K. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007871 · Cited by 19
Methotrexate elicits pro-respiratory and anti-growth effects by promoting AMPK signaling
Papadopoli, D. J., Ma, E. H., Roy, D. G., Russo, M. D. S. T., Bridon, G., Avizonis, D. Z., Jones, R. G., & St‐Pierre, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-64460-z · Cited by 20
Chen, L., Liu, H., Ji, Y., Ma, Z., Shen, K., Shangguan, X., Qian, H., Zhao, Y., Pan, C.-W., & Xue, W. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113138 · Cited by 17
Rewired Metabolism of Amino Acids and Its Roles in Glioma Pathology
Chen, S., Jiang, J., Shen, A., Miao, Y., Cao, Y., Zhang, Y., Cong, P., & Gao, P. (2022) · Metabolites · doi:10.3390/metabo12100918 · Cited by 17
Jasra, I. T., Cuesta‐Gomez, N., Verhoeff, K. K., Marfil‐Garza, B. A., Dadheech, N., & Shapiro, A. M. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1236472 · Cited by 17
Sánchez‐Castillo, A., & Kampen, K. R. (2024) · Discover Oncology · doi:10.1007/s12672-024-01544-6 · Cited by 18
Liu, T., Kuwana, T., Zhang, H., Heiden, M. G. V., Lerner, R. A., & Newmeyer, D. D. (2019) · PLoS Biology · doi:10.1371/journal.pbio.2004413 · Cited by 17
Chen, W., Zhang, W., Wu, R., Cai, Y., Xue, X., & Cheng, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10869 · Cited by 17
Self-citationUbonprasert, S., Jaroensuk, J., Pornthanakasem, W., Kamonsutthipaijit, N., Wongpituk, P., Mee-udorn, P., Rungrotmongkol, T., Ketchart, O., Chitnumsub, P., Leartsakulpanich, U., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007454 · Cited by 17
Kałuzińska‐Kołat, Ż., Kołat, D., Bednarek, A. K., & Płuciennik, E. (2021) · Cancers · doi:10.3390/cancers13122955 · Cited by 17
One-carbon metabolism in cancer cells: a critical review based on a core model of central metabolism
Mazat, J. (2021) · Biochemical Society Transactions · doi:10.1042/bst20190008 · Cited by 16
Evidence from a large-scale meta-analysis indicates eczema reduces the incidence of glioma
Wang, G., Xu, S., Cao, C., Dong, J., Chu, Y., He, G., & Xu, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.11545 · Cited by 16
Metabolic regulation of species-specific developmental ratesPreprint
Díaz-Cuadros, M., Miettinen, T. P., Sheedy, D., Díaz‐García, C. M., Gapon, S., Hubaud, A., Yellen, G., Manalis, S. R., Oldham, W. M., & Pourquié, O. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.27.457974 · Cited by 16
Zhang, Q., & Li, W. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i4.267 · Cited by 16
Sugarman, A. J., Huynh, L. D., Shabro, A., & Cristofano, A. D. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216304 · Cited by 15
König, S., Straßheimer, F., Brandner, N. I., Schröder, J.-H., Urban, H., Harwart, L. F., Hehlgans, S., Steinbach, J. P., Ronellenfitsch, M. W., & Luger, A. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02145-6 · Cited by 16
Amornwatcharapong, W., Maenpuen, S., Chitnumsub, P., Leartsakulpanich, U., & Chaiyen, P. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.07.017 · Cited by 15
Vastrad, C. M., & Vastrad, B. M. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.07.015 · Cited by 16
Hormonal regulation of glycine decarboxylase and its relationship to oxidative stress
Jog, R., Chen, G., Wang, J., & Leff, T. (2021) · Physiological Reports · doi:10.14814/phy2.14991 · Cited by 16
Metabolic Vulnerabilities in Multiple Myeloma
Lim, J. S. L., Chong, P. S. Y., & Chng, W. J. (2022) · Cancers · doi:10.3390/cancers14081905 · Cited by 15
Wang, F., Yang, L., Sun, J., Zheng, J., Shi, L., Zhang, G., & Cui, N. (2017) · Molecular BioSystems · doi:10.1039/c7mb00139h · Cited by 15
MYC overrides HIF-1α to regulate proliferating primary cell metabolism in hypoxia
Copeland, C. A., Olenchock, B. A., Ziehr, D. R., McGarrity, S., Leahy, K., Young, J. D., Loscalzo, J., & Oldham, W. M. (2023) · eLife · doi:10.7554/elife.82597 · Cited by 12
Sato, Y., Matsuda, S., Maruyama, A., Nakayama, J., Miyashita, T., Udagawa, H., Umemura, S., Yanagihara, K., Ochiai, A., Tomita, M., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01129 · Cited by 15
Lin, W., Tang, Y., Zhang, M., Liang, B., Wang, M., Zha, L., & Yu, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.894584 · Cited by 14
Nakamizo, A., Miyamatsu, Y., Hirose, H., Amano, T., Matsuo, S., Fujiwara, M., Shimamura, T., & Yoshimoto, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-20613-w · Cited by 15
Targeting SHMTs and MTHFDs in cancer: attractive opportunity for anti-tumor strategy
Zhang, X., & Wang, Z. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1335785 · Cited by 13
Abdelmaksoud, N. M., Abulsoud, A. I., Abdelghany, T. M., Elshaer, S. S., Rizk, S. M., Senousy, M. A., & Maurice, N. W. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114150 · Cited by 14
Wu, H., He, B., Duan, S., & Yuan, F. (2019) · BioMed Research International · doi:10.1155/2019/2712185 · Cited by 13
Du, J., Huang, Y., Jing, S., Pei, Y., Qian, Y., & Zeng, Y. (2022) · Translational Cancer Research · doi:10.21037/tcr-21-2485 · Cited by 12
Han, W., Wang, S., Qi, Y., Wu, F., Tian, N., Qiang, B., & Peng, X. (2022) · iScience · doi:10.1016/j.isci.2022.104823 · Cited by 13
Singh, M., Warita, K., Warita, T., Faeder, J. R., Lee, R., Sant, S., & Oltvai, Z. N. (2018) · Scientific Reports · doi:10.1038/s41598-018-27266-8 · Cited by 14
Mallette, E., & Kimber, M. S. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00464 · Cited by 12
Hangel, G. J., Lazen, P., Sharma, S., Hristoska, B., Cadrien, C., Furtner, J., Rausch, I., Lipka, A., Niess, E., Hingerl, L., et al. (2022) · Cancers · doi:10.3390/cancers14092163 · Cited by 12
Chen, S., Zhang, S., Feng, W., Li, J., Yuan, Y., Li, W., Wang, Z., Yang, Y., & Liu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1072253 · Cited by 14
Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction
Coleman, M. F., O’Flanagan, C. H., Pfeil, A. J., Chen, X., Pearce, J. B., Sumner, S., Krupenko, S. A., & Hursting, S. D. (2021) · Nutrients · doi:10.3390/nu13051637 · Cited by 12
Macpherson, J. A., & Anastasiou, D. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.03.022 · Cited by 12
Ziehr, D. R., Li, F., Parnell, K. M., Krah, N. M., Leahy, K. J., Guillermier, C., Gao, C., Prell, S. A., Vigder, N., Poli, S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.ads2673 · Cited by 16
Du, B., Zhang, Y., Zhang, P., Zhang, M., Yu, Z., Li, L., Hou, L., Wang, Q., Zhang, X., & Zhang, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-71211-x · Cited by 11
Sánchez‐Castillo, A., Savelkouls, K. G. M., Baldini, A., Hounjet, J., Sonveaux, P., Verstraete, P., Keersmaecker, K. D., Dewaele, B., Björkblom, B., Melin, B. S., et al. (2024) · Oncogenesis · doi:10.1038/s41389-024-00540-3 · Cited by 11
The role and research progress of serine metabolism in tumor cells
Lyu, H., Bao, S., Cai, L., Wang, M., Liu, Y., Sun, Y., & Hu, X. S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1509662 · Cited by 13
Zeng, H., Hu, L., Chen, X., Han, Q., Li, H., Cheng, L., & Li, C.-X. (2023) · Molecules · doi:10.3390/molecules28041595 · Cited by 11
Xiong, W., Ge, H., Shen, C., Li, C., Zhang, X., Tang, L., Shen, Y., Lu, S., Zhang, H., & Wang, Z. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00918-x · Cited by 11
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphomaPreprint
Ma, M. C. J., Tadros, S., Bouska, A., Heavican, T., Yang, H., Deng, Q., Moore, D., Akhter, A., Hartert, K., Jain, N., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/674259 · Cited by 10
Glycine metabolomic changes induced by anticancer agents in A549 cells
Guo, K., Cao, Y., Li, Z., Zhou, X., Ding, R., Chen, K., Liu, Y., Qiu, Y., Wu, Z., & Fang, M. (2020) · Amino Acids · doi:10.1007/s00726-020-02853-0 · Cited by 13
The effect of neurosphere culture conditions on the cellular metabolism of glioma cells
Kahlert, U. D., Koch, K., Suwala, A. K., Hartmann, R., Cheng, M., Maciaczyk, D., Willbold, D., Eberhart, C. G., Glunde, K., & Maciaczyk, J. (2015) · Folia Neuropathologica · doi:10.5114/fn.2015.54422 · Cited by 9
Yu, H., Hu, X., Zhang, Y., Wang, J., Ni, Z., Wang, Y., & Zhu, H. (2023) · Medical Oncology · doi:10.1007/s12032-023-02076-9 · Cited by 9
Shao, M., Pan, Q., Tan, H., Wu, J., Lee, H. W., Huber, A. D., Wright, W. C., Cho, J., Yu, J., Peng, J., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.101079 · Cited by 8
Wang, S.-Q., Liu, N., Zhang, Q., Li, B., Zhao, F.-Y., Li, C., Wang, H., & Liu, C. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07445-y · Cited by 8
Cancer stem cells amino acid metabolism: Roles, mechanisms, and intervention strategies
Gong, Y., Wang, X., Chen, W., Tsai, H., & Liu, Y. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111903 · Cited by 9
Self-citationDigital twins for in vivo metabolic flux estimations in patients with brain cancer
Meghdadi, B., Al‐Holou, W. N., Scott, A. J., Mittal, A., Liang, N., Palavalasa, S., Achreja, A., O’Brien, A. M., Do, K., Wu, Z., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.022 · Cited by 8
Farris, J. D., Alam†, M. S., Rajashekara, A. M., & Haldar, K. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009307 · Cited by 8
Wilczak, J., Prostek, A., Dziendzikowska, K., Gajewska, M., Kopiasz, Ł., Harasym, J., Oczkowski, M., & Gromadzka-Ostrowska, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094635 · Cited by 8
PRMT7 in cancer: Structure, effects, and therapeutic potentials
Yang, G., Liu, Y., Chen, R.-Y., Shi, J., Li, C.-Y., Wang, R., Lu, J., Yu, B., Zhang, L., Yu, B., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117103 · Cited by 8
A new view on functions of the lysine demalonylase activity of SIRT5
Nahálková, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121572 · Cited by 8
Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer.
Li, J., Bo, Y., Ding, B., & Wang, L. (2023) · PubMed Central · doi:10.22074/cellj.2022.557384.1046 · Cited by 7
Jiang, W.-R., Zhang, T., Zhang, H., Han, T.-L., Ji, P., & Ou, Z. (2023) · Biomolecules · doi:10.3390/biom13121806 · Cited by 7
The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer
Shan, Y., Liu, D., Li, Y., Wu, C. L., & Ye, Y. (2024) · PeerJ · doi:10.7717/peerj.16594 · Cited by 7
Reprogramming of leukemic cell metabolism through the naphthoquinonic compound Quambalarine B
Vališ, K., Grobárová, V., Hernychová, L., Bugáňová, M., Kavan, D., Kalous, M., Černý, J., Stodůlková, E., Kuzma, M., Flieger, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21663 · Cited by 7
In silico analysis of expression and DNA methylation profiles of NLRP13 inflammasome in tumor cells
Caldiran, F. Y., Berkel, Ç., Deveci, K., & Çaçan, E. (2022) · Human Gene · doi:10.1016/j.humgen.2022.201067 · Cited by 7
Bierhals, C. G., Howard, A., & Hirst, B. H. (2021) · Biomedicines · doi:10.3390/biomedicines9121770 · Cited by 7
Miao, L.-L., Wang, J., Liu, H.-H., Gao, S., Fan, Y.-C., & Wang, K. (2023) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2023.02.011 · Cited by 8
Deuterium MRI of serine metabolism in mouse models of glioblastoma
Hesse, F., Low, J. C. M., Cao, J., Bulat, F., Kreis, F., Wright, A. J., & Brindle, K. M. (2024) · Magnetic Resonance in Medicine · doi:10.1002/mrm.30198 · Cited by 6
Ota, T., Senoo, A., Shirakawa, M., Nonaka, H., Saito, Y., Itô, S., Ueno, G., Nagatoishi, S., Tsumoto, K., & Sando, S. (2021) · iScience · doi:10.1016/j.isci.2021.102036 · Cited by 6
Chen, Y. D., Gao, K. X., Wang, Z., Deng, Q., Chen, Y. T., & Liang, H. (2022) · World Journal of Oncology · doi:10.14740/wjon1539 · Cited by 6
Aboud, O., Liu, Y., Dahabiyeh, L. A., Abuaisheh, A., Li, F., Aboubechara, J. P., Riess, J. W., Bloch, O. G., Hodeify, R. F., Tagkopoulos, I., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11082261 · Cited by 6
Zhang, Y., Huang, H., Liu, P., & Xie, Y. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad073 · Cited by 6
Righi, V., García‐Martín, M. L., Mucci, A., Schenetti, L., Tugnoli, V., López‐Larrubia, P., & Cerdán, S. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00130 · Cited by 7
Shi, M., Huai, Y., Deng, T., Zhang, C., Song, J., Wang, J., Zhang, Y., Chen, Z., Zhao, H., Wu, K., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102499 · Cited by 5
RNA-mediated inhibition of mitochondrial SHMT2 impairs cancer cell proliferation
Liberati, F., Spizzichino, S., Russo, S. D., Borsatti, G. E., Riva, A., Magnifico, M., Bouzidi, A., Giardina, G., Arese, M., Rossi, C. S., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02646-y · Cited by 4
Mitochondrial respiration supports cancer growth independent of OXPHOS
Chinopoulos, C. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189593 · Cited by 5
Serine hydroxymethyl transferase is required for optic lobe neuroepithelia development in Drosophila
Silva, E. A. B., Venda, A. M. R., & Homem, C. C. F. (2023) · Development · doi:10.1242/dev.201152 · Cited by 5
PRMT7: a survive-or-die switch in cancer stem cells
Nicot, C. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01602-z · Cited by 5
New Insights into the Link Between Melanoma and Obesity
Neagu, M. T., & Dobre, E.-G. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_28 · Cited by 4
Wang, J., Chen, G., Wu, J., & Li, J. (2018) · Tumor and Microenvironment · doi:10.4103/tme.tme_8_18 · Cited by 4
Are anti-glutamic acid decarboxylase 65-kDa isoform antibodies related to diabetes or brain tumor?
Maimaiti, B., Mijiti, S., Sun, H., Xie, Y., Jiang, T., Meng, Q., & Meng, H. (2022) · European journal of medical research · doi:10.1186/s40001-022-00674-3 · Cited by 4
Fiddler, J. L., Blum, J., Heyden, K. E., Castillo, L. F., Thalacker‐Mercer, A. E., & Field, M. S. (2023) · Genes & Nutrition · doi:10.1186/s12263-023-00724-3 · Cited by 4
Proteomic landscape of primary and metastatic brain tumors for heterogeneity discovery
Yang, S., Zhou, C., Zhang, L., Xiong, Y., Zheng, Y., Bian, L., & Liu, X. (2023) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202300010 · Cited by 3
Targeting Tumor Metabolism to Overcome Radioresistance
Wahl, D. R., Petronek, M. S., Rashmi, R., Floberg, J. M., Allen, B. G., & Schwarz, J. K. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_10 · Cited by 4
Kriplani, P. (2022) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892817666220804142633 · Cited by 4
Chen, X., Xu, Q., & Hai-bing, Y. (2024) · Environmental Toxicology · doi:10.1002/tox.24379 · Cited by 3
LncRNAs in hypoxic microenvironment; insight in their impact in cancer biology
Kuriakose, B. B., Hjazi, A., Saleh, R. O., Bishoyi, A. K., Jyothi, S. R., Almalki, S. G., Sridevi, G., Chaudhary, K., Zwamel, A. H., & Matchonov, O. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01635-9 · Cited by 3
Tiwari, V., Ganji, S., An, Z., Pinho, M. C., Davis, L. T., McKnight, C. D., Berry, J. D., Mobley, B. C., Luo, L. Y., Mohler, A. C., et al. (2025) · NMR in Biomedicine · doi:10.1002/nbm.70153 · Cited by 5
Imado, Y., Takahashi, M., Soma, Y., Aburaya, S., Nakatani, K., Hanai, T., Bamba, T., & Izumi, Y. (2026) · Mass Spectrometry · doi:10.5702/massspectrometry.a0188 · Cited by 3
Metabolic remodeling and immune evasion in glioblastoma: a focus on serine and lipid networks
Jiang, D., Wang, C., Zhao, Y., & Li, Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1676560 · Cited by 3
Wang, M., Sun, G., Fan, Y., Sima, G., Sun, X., Qiu, T., & Li, X. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01621-x · Cited by 3
Upregulated Expression of SHMT2 Predicts Poor Survival of Lung Adenocarcinoma
Guo, Q., Huang, G.-H., Chen, P., & Guo, C. (2025) · Genetics Research · doi:10.1155/genr/6104753 · Cited by 3
Fluxomics reveals cellular and molecular basis of increased renal ammoniagenesis
Mpabanzi, L., Wainwright, J., Boonen, B., van Eijk, H. M. H., Dhar, D. K., Karssemeijer, E., Dejong, C. H. C., Jalan, R., Schwartz, J., Damink, S. W. M. O., et al. (2022) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00257-2 · Cited by 3
Biogenic Amines in Gliomas: A Comprehensive Literature Review
Abuaisheh, A., & Aboud, O. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2807141 · Cited by 4
Liu, J., Zhou, Y., Feng, J., Cai, C., & Zhang, S. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1533506 · Cited by 2
Metadata
- Authors
- Kim, D., Fiske, B. P., Birsoy, K., Freinkman, E., Kami, K., Possemato, R. L., Chudnovsky, Y., Pacold, M. E., Chen, W. W., Cantor, J. R., Shelton, L. M., Gui, D. Y., Kwon, M., Ramkissoon, S. H., Ligon, K. L., Kang, S. W., Snuderl, M., Vander Heiden, M. G., & Sabatini, D. M.
- Affiliations
- Broad Institute (US)
- Human Metabolome Technologies, Inc. (Japan) (JP)
- Whitehead Institute for Biomedical Research (US)
- Brigham and Women's Hospital (US)
- NYU Langone Health (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Venue
- Nature
- Published
- 2015-04
- Volume
- 520
- Issue
- 7547
- Pages
- 363-367
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4533874
- OpenAlex
- W1993238514
- Cited by
- 368
- References
- 44
- Citations by year
- 2026: 25 · 2025: 22 · 2024: 21 · 2023: 28 · 2022: 41 · 2021: 42 · 2020: 25 · 2019: 39 · 2018: 34 · 2017: 30 · 2016: 42 · 2015: 18
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Radboud Repository (Radboud University) (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (5-P30-CA14051, CA129105, K99CA168940, CA103866, R01CA103866, R01CA168653, R01CA129105, R00CA168940, P30CA014051)
- National Institute of General Medical Sciences (T32GM007753, T32GM007287)
- National Institute of Allergy and Infectious Diseases (AI-07389, T32AI007389, R37AI047389)
- National Institute of Neurological Disorders and Stroke (K08NS087118)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- SHMT2, glycine decarboxylase, glioblastoma, serine metabolism, glycine metabolism, oxygen consumption, PKM2, methylglyoxal, aminoacetone, tumor cell survival, tumor hypoxia
- MeSH terms
- Acetone, Animals, Brain Neoplasms, Cell Survival, Female, Glioblastoma, Glycine, Humans, Ischemia, Necrosis, Oxygen Consumption, Pyruvaldehyde, Pyruvate Kinase, Glycine Hydroxymethyltransferase, Cell Hypoxia, Xenograft Model Antitumor Assays, Cell Line, Tumor, Glycine Dehydrogenase (Decarboxylating), Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review